CME: Heart-to-Heart Clinical Intensive: Considerations for Rhythm Control Post CABANA

Heart-to-Heart Clinical Intensive: Considerations for Rhythm Control Post CABANA

Heart-to-Heart Clinical Intensive: Considerations for Rhythm Control Post CABANA

How can you manage atrial fibrillation in the post-CABANA era using anti-arrhythmic and anticoagulation strategies?

Available credits: 0.25

Time to complete: 15 Minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    This case discussion activity was recorded at a live meeting in Short Hills, NJ on October 17, 2019. The meeting included renown electrophysiologists Drs. Suneet Mittal (Valley Health System), Jagmeet P. Singh (Massachusetts General Hospital), John M. Miller (Krannert Institute of Cardiology), and Andrew E. Epstein (University of Pennsylvania). Join Dr. Miller as he presents a case focused on managing atrial fibrillation that highlights critical management challenges and therapeutic options for rhythm control and stroke prevention. Dr. Mittal moderates the panel discussion that provides insights and pearls for clinicians who manage patients with this disorder. Slides by the other faculty are provided in the Resources section.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.


    Suneet Mittal, MD FACC FHRS
    Director, Electrophysiology
    Associate Chief of Cardiology
    Medical Director, Snyder AF Center
    Director, Cardiac Research
    Valley Health System
    New York, NY

    Financial Disclosure:
    Consulting Fees: Abbott, Boston Scientific, Medtronic, SentreHEART


    Andrew E. Epstein, MD, FAHA, FACC, FHRS

    Professor of Medicine 
    Electrophysiology Section, Cardiovascular Division
    University of Pennsylvania
    Chief, Cardiology Section
    Philadelphia VA Medical Center
    Philadelphia, PA

    Financial Disclosure:
    No Relationship reported

    John M. Miller, MD
    Professor of Medicine
    Indiana University School of Medicine
    Director, Clinical Cardiac Electrophysiology
    Krannert Institute of Cardiology
    Indianapolis, IN 

    Financial Disclosure:
    Royalty: Elsevier Publishing Co.
    Consulting Fees: Biosense-Webster, Inc.
    Speakers Bureau: Abbott Electrophysiology, Biosense-Webster, Inc., Biotronik, Inc., Boston Scientific Corp., Medtronic, Inc.
    Fellowship Training Grants: Biosense-Webster, Inc., Biotronik, Inc., Boston Scientific Corp., Medtronic, Inc. 

    Jagmeet P. Singh, MD, MSc, DPhil
    Associate Chief, Cardiology Division
    Roman W. DeSanctis Endowed Chair in Cardiology 
    Professor of Medicine, Harvard Medical School
    Massachusetts General Hospital
    Boston, MA

    Financial Disclosure:
    Consulting Fees: Abbott, , Boston Scientific, Biotronik, Cardiologs Inc., EBR Inc.,
    Impulse Dynamics, Medtronic, Microport Inc., Nopras Tech. Inc, Orchestra BioMed Inc., Toray Inc.

    Reviewers/Content Planners/Authors:
    Ben Caref, PhD has nothing to disclose.

  • Learning Objectives

    The goal of this activity is to enable effective collaboration and communication between the members of the professional teams who care for patients with atrial fibrillation. After participating in this educational activity, participants should be better able to:

    After participating in this educational activity, participants should be better able to:

    • Define the challenges associated with achieving sinus rhythm in patients with AF and the rationale for making sinus rhythm an important achievable goal in specific patient subgroups
    • Define the challenges and benefits associated with rate or rhythm control strategies in patients with AF and the therapeutic options for each strategy 
    • Employ an evidence-based approach for reducing thromoboembolic risk in patients with AF.
  • Target Audience

    This activity is designed to meet the educational of Cardiologists, electrophysiologists, internal medicine physicians, primary care physicians, and allied health professionals who treat heart failure.

  • Accreditation and Credit Designation Statements

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Global Learning Collaborative (GLC) and Medtelligence. GLC is accredited by the ACCME to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Dedicated to the creation and execution of the highest quality, evidence-based continuing medical education (CME) initiatives, we utilize multiple learning opportunities for the primary goal of improving healthcare delivered to patients through sharing of research, knowledge, and clinical practice skills.

  • Commercial Support

    This activity is supported by an independent educational grant from Sanofi US.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Medtelligence. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Medtelligence you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited.

    Reproduction of this material is not permitted without written permission from the copyright owner.

Facebook Comments


We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free